US.DGX · Quest Diagnostics

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.1264255319148937,
        "turnoverUsdM": 187.906,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DGX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 225.0058,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 2.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.3,
      "take_profit_price": 246.75,
      "target_multiplier": 1.9,
      "technical_strength": 1.53,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.252851063829787,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 66.9,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.9,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 233.6375,
    "ma50": 237.4268,
    "close": 235,
    "prevClose": 239.15,
    "avgVolume20": 1125040,
    "volumeRatio": 0.71,
    "changePercent": -1.74
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": 0.01744815343984074,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 0.6768814018454246,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 1.5087646407284263,
      "volat_points": 4,
      "day_range_pct": 0.030595744680851054,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 66.9,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 74,
        "contribution": 3.7
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 9.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 62.67,
        "contribution": 9.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 18.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60.67,
        "contribution": 18.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.9,
    "details": [
      "基本面分析總分: 3.7/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 9.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 18.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.7,
      "資金流": 12.4,
      "市場環境": 9.4,
      "情緒分析": 6,
      "技術信號": 18.2,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.4,
          "epsPoints": 0.4,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 187.906,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 2.4,
          "obvPoints": 4,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DGX",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.46
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 742.51900315,
                "ma50": 726.7734006600002,
                "name": "QQQ",
                "close": 709.79999,
                "points": 0.4
              },
              "spy": {
                "ma20": 771.1839966499999,
                "ma50": 768.5017965800001,
                "name": "SPY",
                "close": 763.25,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.1264255319148937,
          "atrPoints": 3,
          "cciPoints": 3.2,
          "vixPoints": 2.4,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 1.4
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142761026,
                "url": "https://finnhub.io/api/news?id=1676261a65a438a7a3a61ceabcb8696ce8ba7f0cdb4111761a736fa3785ce588",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) clears ChartMill's Best Dividend screen with a 2.1% yield, strong profitability, safe payout, and 10+ years of dividend growth.",
                "category": "company",
                "datetime": 1791550252,
                "headline": "Quest Diagnostics (NYSE:DGX): A Dividend Quality Pick for Income Investors"
              },
              {
                "id": 142585164,
                "url": "https://finnhub.io/api/news?id=c14559120db2f57df66e587525bcdda409c7cb52a100639654670318b7ba7321",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) scores 7 for trend and 8 for setup, with a defined breakout entry above 237.95 and support near 230.87.",
                "category": "company",
                "datetime": 1790938238,
                "headline": "Quest Diagnostics (NYSE:DGX) Breakout Setup Backed by Technical Rating 7 and Setup Rating 8"
              },
              {
                "id": 142363328,
                "url": "https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...",
                "category": "company",
                "datetime": 1790183582,
                "headline": "Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"
              },
              {
                "id": 142343168,
                "url": "https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...",
                "category": "company",
                "datetime": 1790111776,
                "headline": "Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"
              },
              {
                "id": 142338105,
                "url": "https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.",
                "category": "company",
                "datetime": 1790080080,
                "headline": "Is This the Right Time to Add DGX Stock to Your Portfolio?"
              }
            ],
            "raw_source": [
              {
                "id": 142950979,
                "url": "https://finnhub.io/api/news?id=d55d2020ea3d6a37407105110c898f3380c2e49b3449b0a523fc8c044b02dc97",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read full analysis here.",
                "category": "company",
                "datetime": 1792173679,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 18"
              },
              {
                "id": 142883187,
                "url": "https://finnhub.io/api/news?id=df66f5276cb53baa566420fe62459f6b065660547d648c42c6cc0bc813b10767",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DGX heads into Q3 earnings with expected revenue and EPS growth, fueled by strong clinical demand, advanced diagnostics and operational efficiencies.",
                "category": "company",
                "datetime": 1791979920,
                "headline": "Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings"
              },
              {
                "id": 142825442,
                "url": "https://finnhub.io/api/news?id=666239ff6707a01d9f688b18c57311f416bab30f6f16b2df1992840c04dfca3d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17.0%. Following that decline, shares now trade at 2.8 times sales, against 3.1 for the index. Yet the company grew sales nearly 40% in fiscal Q2 2026. So where is that growth coming from.",
                "category": "company",
                "datetime": 1791845626,
                "headline": "Should You Trim Or Add To Your Hims & Hers Position Now?"
              },
              {
                "id": 142761026,
                "url": "https://finnhub.io/api/news?id=1676261a65a438a7a3a61ceabcb8696ce8ba7f0cdb4111761a736fa3785ce588",
                "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) clears ChartMill's Best Dividend screen with a 2.1% yield, strong profitability, safe payout, and 10+ years of dividend growth.",
                "category": "company",
                "datetime": 1791550252,
                "headline": "Quest Diagnostics (NYSE:DGX): A Dividend Quality Pick for Income Investors"
              },
              {
                "id": 142732196,
                "url": "https://finnhub.io/api/news?id=34a7dbc69f906b564100807a1a19adc18f40e295ccba5952839465f42c9e30ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Oracle director Stephen Rusckowski bought 25,000 shares as reports about OpenAI’s revenue fueled swings in the cloud provider’s stock.",
                "category": "company",
                "datetime": 1791485700,
                "headline": "Oracle Insider Buys $3.5 Million in Stock Amid OpenAI Swings"
              },
              {
                "id": 142696923,
                "url": "https://finnhub.io/api/news?id=af7eb7e9c15b035c266b462cb988511c7c7c2a3a3d36b2283415d8f6e53bf30e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1394005030/image_1394005030.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Natera is rated Sell, as its valuation is stretched, with perfect execution priced in, despite looming competitive threats. Click to read more about NTRA.",
                "category": "company",
                "datetime": 1791373949,
                "headline": "Natera: Priced To Perfection Amidst Rising Competitive Threats"
              },
              {
                "id": 142728283,
                "url": "https://finnhub.io/api/news?id=0fe45e79d171c2e8dbffbf27602ac364a2bb692bef8477532651b8f3be67d1a9",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Barclays  analyst Luke Sergott   maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises the price target from $250 to $260.",
                "category": "company",
                "datetime": 1791371837,
                "headline": "Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $260"
              },
              {
                "id": 142664476,
                "url": "https://finnhub.io/api/news?id=293a1e63d2d9f8d35ccf43537079ef2352e40d44a0deea52ecbe4d188ab55d23",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.",
                "category": "company",
                "datetime": 1791297302,
                "headline": "Tuesday's session: gap up and gap down stock in the S&P500 index"
              },
              {
                "id": 142807153,
                "url": "https://finnhub.io/api/news?id=e92046e308d4620c73845da54ed92b68656e124fbed6946590a065983126f8a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 117 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
                "category": "company",
                "datetime": 1791219564,
                "headline": "Dollar Tree Upgraded, Kroger Downgraded: Updated Rankings on Top Blue-Chip Stocks"
              },
              {
                "id": 142637942,
                "url": "https://finnhub.io/api/news?id=07105389560df4f299290f754ad86387b2c33e24058f7a0390dadae853dc64be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics is set to report its Q3 earnings next month, with analysts expecting single-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1791199879,
                "headline": "Quest Diagnostics’ Quarterly Earnings Preview: What You Need to Know"
              },
              {
                "id": 142635068,
                "url": "https://finnhub.io/api/news?id=d7b2c7fb282022bc3e12941ef582df025af31c77426788b23691e29a499cc6d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "TMO, CRCT and SHOP delivered strong gains as Zacks highlighted standout performers across its research portfolios.",
                "category": "company",
                "datetime": 1791198540,
                "headline": "Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus"
              },
              {
                "id": 142593872,
                "url": "https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengers—see dividend changes, upcoming ex-dividend and pay dates. Read it here.",
                "category": "company",
                "datetime": 1790965134,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 4"
              },
              {
                "id": 142585164,
                "url": "https://finnhub.io/api/news?id=c14559120db2f57df66e587525bcdda409c7cb52a100639654670318b7ba7321",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) scores 7 for trend and 8 for setup, with a defined breakout entry above 237.95 and support near 230.87.",
                "category": "company",
                "datetime": 1790938238,
                "headline": "Quest Diagnostics (NYSE:DGX) Breakout Setup Backed by Technical Rating 7 and Setup Rating 8"
              },
              {
                "id": 142561873,
                "url": "https://finnhub.io/api/news?id=843c5e04d0476440d20d651772146e076293c2cdf68a5577a91ad8d377a61c2e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Like runners striving to break from the pack, a slew of wearables companies are competing for share of consumers’ health and fitness tracking habits.  With  Apple  latest heart-rate focused updates to its best-selling Apple Watch and an upcoming Health app redesign, it’s hoping to expand an already impressive lead.  Users will be able to calculate their “health age”—a comparison of their overall health measurements with their actual age—as well as a Readiness score that gauges capacity for strenuous activity.",
                "category": "company",
                "datetime": 1790870640,
                "headline": "Apple Is Betting Improved Heart and Health Insights Will Boost Watch Sales"
              },
              {
                "id": 142560736,
                "url": "https://finnhub.io/api/news?id=a2c920a63526fb0e12ed89106e04a060a1d8a4af80f71f822982c6e9fd42aad5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Like runners striving to break from the pack, a slew of wearables companies are competing for share of consumers’ health and fitness tracking habits.  With  Apple  latest heart-rate focused updates to its best-selling Apple Watch and an upcoming Health app redesign, it’s hoping to expand an already impressive lead.  Users will be able to calculate their “health age”—a comparison of their overall health measurements with their actual age—as well as a Readiness score that gauges capacity for strenuous activity.",
                "category": "company",
                "datetime": 1790870640,
                "headline": "Apple’s Betting Improved Heart and Health Insights Will Boost Watch Sales"
              },
              {
                "id": 142558111,
                "url": "https://finnhub.io/api/news?id=08ef20b2a39ff3857053cbb3f47ea5cb28e608dc75e1cef2e83c0285afeb17c2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "A new study published in The Journal of Molecular Diagnostics showed that the Haystack MRD® test is highly accurate at detecting residual and recurrent disease, demonstrating clinical performance in specimens from the landmark DYNAMIC colorectal cancer trial series. The study also validated the test’s analytical performance across 23 solid tumor types. Provided by Quest Diagnostics (NYSE: DGX), Haystack MRD is an ultrasensitive circulating tumor DNA (ctDNA) liquid biopsy test for identifying res",
                "category": "company",
                "datetime": 1790859120,
                "headline": "Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials"
              },
              {
                "id": 142515528,
                "url": "https://finnhub.io/api/news?id=b868a1c8ce752ff61f5d5c38f1b069c442f8ff00d26ca83dcf650a8896dfc6e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Who We Play For, a nonprofit that championed Florida's Second Chance Act, Myelai, and Unless Health today announce the launch of a cardiac screening program at Quest Diagnostics' Sheldon Road location in Tampa, giving families a fast way to complete the electrocardiogram (ECG) heart screening now required for Florida high school athletes.",
                "category": "company",
                "datetime": 1790773200,
                "headline": "Who We Play For and Myelai Launch Heart Screening Program at Quest Diagnostics in Tampa as Florida Becomes First State to Require ECGs for High School Athletes"
              },
              {
                "id": 142424964,
                "url": "https://finnhub.io/api/news?id=6754993483ef0493cde9e75b72cce17e5c23c7eabbdaa8d127e95ef24b3b6fed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DGX's 36.3% YTD rise reflects momentum in advanced diagnostics, channel growth, AI adoption and cost savings.",
                "category": "company",
                "datetime": 1790334840,
                "headline": "Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?"
              },
              {
                "id": 142363328,
                "url": "https://finnhub.io/api/news?id=04ca053e648e9f19e903df7b13d3267b9144e1d464ad58573b2654ed36a9ed7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) drew fresh attention after announcing an Apple Health integration that allows iPhone and iPad users to order a preventive lab panel with more than 50 biomarkers for US$119. The Apple Health tie-in lands after a strong run in Quest Diagnostics’ shares, with the price up 15.6% over 90 days and 35.1% year to date, even though the last month’s share price return slipped 3.9% as traders reassessed shorter term risk and reward. Scan beyond Quest Diagnostics and see how other...",
                "category": "company",
                "datetime": 1790183582,
                "headline": "Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch"
              },
              {
                "id": 142357932,
                "url": "https://finnhub.io/api/news?id=9e36425fe178bc4709a47624582e481fa85510e74d1222fa56d6866a9e993d90",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2172700551/image_2172700551.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DGX",
                "summary": "Quest Diagnostics outlook: recurring testing demand & acquisitions support growth via hospital partnerships, dialysis & advanced diagnostics. More on DGX stock.",
                "category": "company",
                "datetime": 1790153451,
                "headline": "Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds"
              },
              {
                "id": 142343168,
                "url": "https://finnhub.io/api/news?id=038be9e8835d6646a1edcfd73c166a149aa77b0857c0e85a501ba91781969b3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has delivered a strong run in recent years, which raises a straightforward question for investors who care about fundamentals. Is the current share price still aligned with the cash the business is expected to generate over time, or has sentiment moved ahead of its underlying economics? Over the past 3 years, Quest Diagnostics has returned 108.9%, which puts real weight on whether that gain is grounded in durable cash flows rather than just multiple expansion. A recent...",
                "category": "company",
                "datetime": 1790111776,
                "headline": "Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns"
              },
              {
                "id": 142343169,
                "url": "https://finnhub.io/api/news?id=f51891e6b50a33e2225807bf2c70868ec49a46eace8ca870fd0fa16effd1209e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report its third quarter 2026 financial results on Thursday, October 22, 2026, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.",
                "category": "company",
                "datetime": 1790108880,
                "headline": "Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026"
              },
              {
                "id": 142340992,
                "url": "https://finnhub.io/api/news?id=7f9451e056dd0c45a4304b88f0f9ccd9306f02bc7a8be5192dacae80dd8a134d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.",
                "category": "company",
                "datetime": 1790098711,
                "headline": "Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)"
              },
              {
                "id": 142340543,
                "url": "https://finnhub.io/api/news?id=3676ae49763de619be9f5fe2e63a7f07bcf3e24bbc465dc75e6bdb876230f298",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.",
                "category": "company",
                "datetime": 1790096700,
                "headline": "These S&P500 stocks have an unusual volume in today's session"
              },
              {
                "id": 142340388,
                "url": "https://finnhub.io/api/news?id=f2b585db9bcaae9e84130e615a8e8ef41261f486b04f1b7c75b84e8417f50f6d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1790094901,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 142340108,
                "url": "https://finnhub.io/api/news?id=7ba6201b058414a5b6972eb4c07b92c2f611694434c01ec3676864195808afe1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "The government thinks it's been overpaying Quest Diagnostics. They plan to stop doing that next year.",
                "category": "company",
                "datetime": 1790092667,
                "headline": "Why Quest Diagnostics Holdings Stock Dropped Today"
              },
              {
                "id": 142339965,
                "url": "https://finnhub.io/api/news?id=d1b6e8b524d0647dcaeec0b1a5b6abcaaf33defc75d8f66fc0c8d15a8e837148",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid whole genome and exome sequencing, next-generation sequencing, chromosomal microarrays and personalized neonatal care. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes key trends, technologies, segments, regional opportunities and leading companies, in",
                "category": "company",
                "datetime": 1790092440,
                "headline": "NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)"
              },
              {
                "id": 142339145,
                "url": "https://finnhub.io/api/news?id=f0446e18c84e837a73cc227d0f99d6763ecece1442cb743bfc7cda0da9c0f348",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1790087701,
                "headline": "What's going on in today's session: S&P500 gap up and gap down stocks"
              },
              {
                "id": 142338103,
                "url": "https://finnhub.io/api/news?id=4401faec34b0aaa7836bc4c94e2745f0faaa5a933c0af5da81443dbec3f44bcb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.",
                "category": "company",
                "datetime": 1790085600,
                "headline": "Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure"
              },
              {
                "id": 142338104,
                "url": "https://finnhub.io/api/news?id=5215abeb2634d2e41b0915055aa5ef030cbf4b8eecbec9bed4a3c64d0351b745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (DGX) and Labcorp (LH) shares fell in Tuesday premarket trading after the Centers",
                "category": "company",
                "datetime": 1790081212,
                "headline": "Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services"
              },
              {
                "id": 142337151,
                "url": "https://finnhub.io/api/news?id=ec15db9f3538528033e3a2b785c80a05463d3015aa798d3d099f3d82dfb34f1d",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "DGX",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.",
                "category": "company",
                "datetime": 1790080501,
                "headline": "Discover the top S&P500 movers in Tuesday's pre-market session."
              },
              {
                "id": 142338105,
                "url": "https://finnhub.io/api/news?id=0ddb1180ed60687db2d4be2df12a1369e2e796f69a49ec3ce7f075a2a7dce3bb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while reimbursement uncertainty, costs and debt pose challenges.",
                "category": "company",
                "datetime": 1790080080,
                "headline": "Is This the Right Time to Add DGX Stock to Your Portfolio?"
              },
              {
                "id": 142340903,
                "url": "https://finnhub.io/api/news?id=0038cdfe7ff456daae6d1d328d374892016f3ea30e0fa66c2020ba00ba32c252",
                "image": "https://image.cnbcfm.com/api/v1/image/107419247-1716474869682-gettyimages-2120209340-64393_48_ms_2421.jpeg?v=1790098111&w=1920&h=1080",
                "source": "CNBC",
                "related": "DGX",
                "summary": "These are the stocks posting the largest moves midday.",
                "category": "company",
                "datetime": 1790079522,
                "headline": "Stocks making the biggest moves midday: Lennar, Capri, Vicor, Amgen & more"
              },
              {
                "id": 142341306,
                "url": "https://finnhub.io/api/news?id=a71b9de87d209370f6319257c8942174ad27d5b639cb870a2f9cf782b0777741",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1790078212,
                "headline": "Is Quest Diagnostics Stock Outperforming the Nasdaq?"
              },
              {
                "id": 142336978,
                "url": "https://finnhub.io/api/news?id=f1182ee95aa158cd4e64c93fec0fe6aa89a804fc357f25c80bbb04d312374656",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Investing.com - U.S. stock index futures steadied on Tuesday, following a strong session on Wall Street that saw the benchmark S&P 500 post its best day since August, helped by gains in artificial intelligence-linked stocks.",
                "category": "company",
                "datetime": 1790078144,
                "headline": "Premarket movers: Quest, Labcorp hit by CMS cuts"
              },
              {
                "id": 142338041,
                "url": "https://finnhub.io/api/news?id=3e0d174be2c852517a09542bfcb22c078c10e5aab66134bc391405284e08e1bf",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Portland--Or--Usa---Sep-4--2025-Homepage.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "CMS proposes 2027 Medicare lab rates, estimating $1 billion in annual taxpayer savings as payments align with private rates.",
                "category": "company",
                "datetime": 1790064655,
                "headline": "CMS Targets $1 Billion in Annual Savings With new Medicare Lab Payment Rates — Here’s What Could Change in 2027"
              },
              {
                "id": 142338042,
                "url": "https://finnhub.io/api/news?id=5fbe59656eb7c8e519203883d87a9ba7e725d627ad9c93744d9bd2b9cb6b416c",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/Stockholm--Sweden---October-8--2021-An-O.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostics, Rambus and others also declined premarket.",
                "category": "company",
                "datetime": 1790064067,
                "headline": "Ericsson, Lexeo Therapeutics And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session"
              },
              {
                "id": 142340847,
                "url": "https://finnhub.io/api/news?id=1a3dcec5e48d410e2b1bfe59cbaf3923fc48e925527b6fa1ef1214e10e7de391",
                "image": "https://image.cnbcfm.com/api/v1/image/108192542-17564859632025-08-29t163100z_183075094_rc28ggaso5se_rtrmadp_0_on-hldg-results.jpeg?v=1756486078&w=1920&h=1080",
                "source": "CNBC",
                "related": "DGX",
                "summary": "These are the stocks posting the largest moves in early trading.",
                "category": "company",
                "datetime": 1790063373,
                "headline": "Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more "
              },
              {
                "id": 142337396,
                "url": "https://finnhub.io/api/news?id=7491d828c68bc1cb16df1464f12b93a2ed591c42e1565441c46468c4b46e2e1e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/22/The-Real-Villains-No-Longer-Hide.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Vicor jumped 11% premarket after raising Q3 growth guidance above 20%; TOPS, FBGL and QNME led other gainers.",
                "category": "company",
                "datetime": 1790055031,
                "headline": "Why Vicor Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket"
              },
              {
                "id": 142337470,
                "url": "https://finnhub.io/api/news?id=5c389d182d0729ba00bed5398594278c770ae22bb653f7a50cf68140cd412bc9",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Gainers\n\nMilestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. \nEvotec (NASDAQ:EVO) stock rose 8.44% to",
                "category": "company",
                "datetime": 1790010367,
                "headline": "12 Health Care Stocks Moving In Monday's After-Market Session"
              },
              {
                "id": 142314530,
                "url": "https://finnhub.io/api/news?id=351177f1d47b514bcc8a183bc924d38c93b7558751778d3c960cf36c2c1941b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Quest Diagnostics (NYSE:DGX) CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and partnerships rather than a heavier-than-expected pace of acquisitions. D",
                "category": "company",
                "datetime": 1789999330,
                "headline": "Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges"
              },
              {
                "id": 142311097,
                "url": "https://finnhub.io/api/news?id=549978088471503f39ef8adfc2316186f5ce7fc93dab84136070f50605ea2d73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Market uncertainty persists, but Zacks highlights strong gains across key portfolios and stocks, including PBF, PLTR and ADBE",
                "category": "company",
                "datetime": 1789992600,
                "headline": "Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus"
              },
              {
                "id": 142313054,
                "url": "https://finnhub.io/api/news?id=3c78eb32d5eeb8295fa80c578cf9e54fa18cb97df559f696903c7f45af3604e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DGX",
                "summary": "Nearly one in three patients found to have antibodies against the bacterium that causes Lyme disease also had antibodies against one or more additional tick-borne pathogens, according to a new study by researchers from Quest Diagnostics (NYSE: DGX) and the University of North Carolina at Chapel Hill.",
                "category": "company",
                "datetime": 1789992180,
                "headline": "Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics"
              },
              {
                "id": 142312445,
                "url": "https://finnhub.io/api/news?id=a88fe3314c79e8d454a01552d14cb77e1a9437dff5db27b2ceaee866cb1d31e5",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "Truist Securities  analyst David Macdonald   maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target from $250 to $260.",
                "category": "company",
                "datetime": 1789981671,
                "headline": "Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $260"
              },
              {
                "id": 142312446,
                "url": "https://finnhub.io/api/news?id=b85e02d4bea66182a8dbb2ce386581296b35e69bfed6c8f4ef67278e22f613e0",
                "image": "",
                "source": "Benzinga",
                "related": "DGX",
                "summary": "New study by researchers from Quest Diagnostics (NYSE:DGX) and the University of North Carolina at Chapel Hill. Published in JAMA Network Open, the study, titled "Coseropositivity to Tick-Borne Pathogens Among",
                "category": "company",
                "datetime": 1789978088,
                "headline": "Quest Diagnostics Study Indicates That Nearly One In Three Patients With Antibodies Against Bacterium That Causes Lyme Disease Also Had Antibodies Against One Or More Additional Tick-Borne Pathogens"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.4,
            "source_article_count": 45,
            "discarded_article_count": 40
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.2,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1,
          "macdPoints": 3.2,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1,
            "vcp_reason": "跌縮量(近10日3日)；靠近20日高位；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1112056.6666666667,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1062290,
              "avg_vol_20": 1181300,
              "avg_vol_30": 1112056.6666666667,
              "range_pct_10": 0.05697872340425526,
              "range_pct_20": 0.09812765957446809,
              "range_pct_30": 0.09812765957446809,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9552480838806175,
              "dist_to_20d_high": 0.05561806783475327,
              "down_shrink_days": 3,
              "breakout_level_20d": 248.84,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.5806591500433645
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.1264255319148937,
              "turnoverUsdM": 187.906,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DGX",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 225.0058,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 2.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.3,
            "take_profit_price": 246.75,
            "target_multiplier": 1.9,
            "technical_strength": 1.53,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.252851063829787,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 4.9971,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.13
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 65.84
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0274
    },
    "kdj": {
      "d": 59.45,
      "j": 87.61,
      "k": 68.84,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 53.28
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -7466100,
      "recentSlope": 26560,
      "previousSlope": -398180
    },
    "rsi": 46.54,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 226.0478,
      "position": "SAR喺價下",
      "distancePct": 3.81,
      "previousTrend": "上升"
    },
    "ma50": 237.4268,
    "macd": {
      "macd": -1.030234511759744,
      "trend": "看漲",
      "signal": -1.6057593633100589,
      "histogram": 0.5755248515503149
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 233.3768,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 2
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.71,
      "score": 2,
      "avgVolume": 1125040,
      "currentVolume": 799600
    },
    "derived": {
      "ma20": 233.6375,
      "ma50": 237.4268,
      "prevClose": 239.15,
      "avgVolume10": 1032170,
      "avgVolume20": 1125040,
      "changePercent": -1.74,
      "avgVolumeForScore": 1125040
    },
    "ma_cross": {
      "ma20": 233.6375,
      "ma50": 237.4268,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 234.21,
      "prevMa50": 237.4968,
      "spreadPct": 1.6,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 225.8807,
      "upper": 241.3943,
      "position": "上半部"
    },
    "rsi_short": 62.45,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.71
    }
  }
}

{
  "close": 235,
  "volume": 799600,
  "changePercent": -1.74
}